New & Noteworthy

Pseudouridine: Not Just for Noncoding RNA Anymore

September 11, 2014

If you think back really hard to your basic molecular biology classes you can probably remember that weird nucleotide pseudouridine (ψ). You probably learned that it is found in lots of tRNAs and rRNAs but never in mRNA. You also may remember that while its function is still a bit unclear, it may have something to do with RNA stability and/or helping aminoacyl transferases interact with tRNAs.

Like this monument to Stalin that was dynamited in 1962, old dogmas like pseudouridine’s absence from mRNA are being cleared away with help from yeast. Images from Wikimedia Commons

If a new paper in Nature holds up, one of those things we learned is almost certainly wrong. In this study, Carlile and coworkers show pretty convincingly that ψ is also found in mRNA. And not only that, but it may be doing something important there.

The authors used a sensitive high-throughput technique called Pseudo-seq to look for ψ in all the RNA in a yeast cell. The first step in this technique is to treat the RNA with a chemical called CMC.* This chemical reacts with ψ in such a way as to create a block to reverse transcriptase. In other words, reverse transcriptase can only convert RNA into DNA up to the point of a ψ. The next step is to analyze the products and to determine where reverse transcriptase has been halted. 

Carlile and coworkers first validated their technique by looking at RNAs known to have ψ’s. They showed that their technique had an estimated false discovery rate of 5% for highly expressed genes and 12.5% for poorly expressed genes. They were now ready to tackle mRNA to see what they could find.

They first looked at the mRNA of the yeast Saccharomyces cerevisiae during post-diauxic growth (after log phase) and found 260 ψ’s in 238 protein coding transcripts. This is 260 more ψ’s than had been found before.

The next step was to try to get a feel for whether or not these changes were important. To do this, they decided to compare pseudouridylation (we promise not to use that word again!) in log phase and post-diauxic growth. They found that 42% of the sites modified after log phase were not modified during log phase. In other words, it looks like the level of mRNA modification is different depending upon the growth rate. 

Uracils are modified to ψ by a surprisingly large number of enzymes. One enzyme, Cbf5p, uses snoRNA guide sequences to find the right uracils to modify. Cbf5p may not be that important for converting U’s to ψ’s in mRNA , however, since only 3/260 of the sites identified by the authors appeared to be targeted by this enzyme.

E. coli pseudouridine synthase. Image from Wikimedia Commons

The other nine known enzymes in yeast all have the rather unfortunate acronym “PUS,” for PseudoUridine Synthase. Carlile and coworkers tested the effects of individually deleting eight of these on their newly identified ψ sites in mRNA and found that deleting PUS1 affected the highest number of mRNAs.  Interestingly, many of the Pus1p target sites were modified more often during post-diauxic growth than during exponential growth. Deleting the other PUS genes had similar, if smaller, effects. 

The authors next confirmed that something similar happens in human cells. Using very strict criteria, they identified 96 ψ’s in 89 human mRNAs and found that some of these were regulated by growth conditions (serum starvation), just as in yeast. So, modification of mRNAs with this interesting residue appears to happen in people too (or at least in HeLa cells).

Finding ψ’s in mRNA is a big contradiction to everything we’ve been taught!  The next step is to figure out what they are doing there, and there are lots of possible answers.

One possibility is that the newly discovered mRNA modifications make possible a whole new set of translated proteins. Adding a ψ to mRNA changes codon usage at that position in vitro. For example, one study found that converting the stop codons UAA and UGA to ψAA and ψGA, respectively, changed them from stop codons into sense codons both in vitro and in vivo. So ψ’s in mRNAs could cause a whole slew of new alleles to appear under certain conditions – at the RNA level instead of the DNA level. A proteomics study should help determine whether this is happening or not.

Another possibility has to do with the fact that ψ’s make an RNA more stable. Making certain mRNAs more stable could increase the number of protein molecules they can produce: yet another way to affect gene expression post-transcriptionally. A stability study of mRNA and/or more proteomics might help determine whether this is the function of the unusual modifications.

Whatever the reason, it definitely looks like another bit of biological dogma has been overturned with the help of our faithful and reliable friend yeast. Yes Virginia, mRNA almost certainly has the modified nucleotide ψ. And, as usual, thanks to yeast for teaching us the fundamentals of our own basic biology.

* CMC stands for N-cyclohexyl-N′-(2-morpholinoethyl)carbodiimide metho-p-toluenesulphonate

by D. Barry Starr, Ph.D., Director of Outreach Activities, Stanford Genetics

Categories: Research Spotlight

Tags: pseudouridine, RNA modification, Saccharomyces cerevisiae

Yeast as a Painkiller Factory

September 04, 2014

Imagine you were designing a factory to make a very special product.  You’d study the process carefully, buy the right equipment, and bring in the right people. 

To make a tricky product you need to have the right factory, workers and machinery. And if you’re making opiate drugs, then yeast makes a great factory! Image from Wikimedia Commons

So if one step made a lot of dust, while another step had to be dust-free – you’d be sure to separate them into different rooms of your factory.  And you’d make sure that the instructions were written in a language that your experts could understand! 

In a new paper in Nature Chemical Biology, Thodey and coworkers designed a factory in just this way to make some very important molecules: the opiate drugs that millions of people rely on every day to control pain. Because of this new factory, opium poppies won’t be needed for making these drugs (although they’ll still be very pretty!).  The factory’s location: inside cells of our favorite yeast, S. cerevisiae.

The researchers first tried to coax the yeast to produce the natural opiates morphine and codeine. They recruited experts in the field (or, from the field), taking three opium poppy genes for enzymes in the opiate synthesis pathway: thebaine 6-O-demethylase (T6ODM), codeine O-demethylase (CODM), and codeinone reductase (COR).

Of course, simply transforming yeast with a plant gene doesn’t do much good.  Yeast and poppies don’t speak the same language at the transcription level (and even their translation dialects are hard to understand).  So the researchers put the poppy genes under the control of efficient yeast transcriptional regulatory sequences such as promoters and terminators, and optimized their codons for yeast.

Thodey and colleagues tweaked the system to try to steer it in the direction of the products they wanted. They fed the yeast additional monosodium glutamate and glutamine to increase intracellular levels of 2-oxoglutarate, which is required during catalysis by the T6ODM and CODM enzymes. They also varied the relative expression levels of the three poppy enzymes by varying the copy numbers of their genes in yeast.

Although these tweaks improved things, almost half the product was still the undesirable neomorphine. To address this, the researchers looked even more closely at the details of the pathway.

When morphine synthesis is going right, the neopinone made by T6ODM spontaneously rearranges to the codeinone that COR uses to continue along the pathway.  But if COR grabs the neopinone before there is time for the rearrangement, the end result of the pathway is neomorphine, which does no one any good.

When you design a factory, it’s important that your assembly line doesn’t move too fast! In the yeast factory, when neopinone gets to the COR enzyme too quickly, the end result is not what you want – although maybe not this messy.

Going back to their blueprint, Thodey and colleagues decided to separate T6ODM and COR into different parts of the factory, to allow more time for this rearrangement. They added a tag to COR that would direct it to the endoplasmic reticulum membrane, while T6ODM stayed in the cytoplasm. Now it would take longer for neopinone to reach COR, giving it plenty of time to rearrange into codeinone. Sure enough, morphine production went way up.

This was great, but the researchers decided to take it a step further. Semisynthetic opioids such as hydrocodone, oxycodone, and hydromorphone are medically useful because they work better in some cases than the natural opiates. Currently, these are produced by chemical modification of the opiates produced by poppies. Could yeast do this job too?  Of course!

Turning to different expert workers, Thodey and colleagues tried expressing the enzymes NADP+-dependent morphine dehydrogenase (morA) and NADH-dependent morphinone reductase (morB) from the bacterium Pseudomonas putida* along with the poppy enzymes. Again, the process needed a lot of tweaking, more than we can describe here. But the end result was a strain that produced both hydrocodone and oxycodone.

Putting together all their results, the researchers were able to construct three yeast strains, each like an assembly line tailored for different products. One assembly line is optimized for codeine and morphine, another for hydromorphone, and one for hydrocodone and oxycodone.

The next steps will be to scale up this process to industrial levels, and also to construct yeast strains that carry out the entire process starting from simple sugars, rather than needing to be fed the precursor thebaine. Substituting yeast cultures for opium poppy fields will have a huge global impact that goes far beyond pharmaceutical production.

It’s important to note that this factory could never have been constructed without knowing how to make its fundamental building blocks. Basic research in yeast molecular biology and genetics, which may seem arcane to some, was essential to provide the knowledge necessary to express and manipulate these foreign genes in yeast. Just another reason that we’re “high” on yeast research!

* Read more about Pseudomonas putida, a bacterial workhorse with an appetite for all kinds of weird substances.

by Maria Costanzo, Ph.D., Senior Biocurator, SGD

Categories: Research Spotlight

Tags: opiate biosynthesis, pathway engineering, Saccharomyces cerevisiae

RNase P, Unmasked

August 28, 2014

No matter how fancy, all masks hide the identity of a wearer. And no matter how fancy an RNase P is, all it likely does is trim tRNA precursors. Images from Wikimedia Commons

Masks for a masquerade party come in a dazzling array of shapes and sizes.  And yet they all pretty much serve the same purpose — they hide the identity of the wearer.

Biology sometimes has its own dazzling array of cellular machines all doing the same thing.  One of the best examples of this is RNase P.   This enzyme trims tRNA precursors into mature tRNAs and has pretty much been around in one form or another since there were cells.  And yet, despite this common heritage and its one apparent job, it seems that no two are exactly alike.

In bacteria, RNase P is a piece of RNA that serves as the enzymatic component, complexed with a single protein.  Most Archaea and eukaryotes kept the RNA and added a varying number of protein subunits to make some wildly complex enzymes.  But in a few eukaryotes, the RNA has been dropped completely and a single protein substituted to provide the enzymatic activity. 

A new study out in PLOS Biology by Weber and coworkers shows that, despite this structural diversity, all the different forms of RNase P pretty much do the same thing.  Just like someone can hide who they are with any old mask, a cell can trim its tRNA precursors with any old RNase P.  Well, at least the simple RNase P of Arabidopsis thaliana, comprised of a single enzymatic protein subunit, can replace the enzymatic RNA and at least one protein subunit from the much more complex RNase P of our friend Saccharomyces cerevisiae!

This suggests that evolution has done something weird here.  It took what most likely started out as an RNA enzyme and made various changes to it over time.  Despite these changes, the enzyme kept doing the same thing: trimming tRNA precursors.  It is as if the enzyme went through a bewildering set of evolutionary changes and ended up at nearly the same place doing the same thing.   

How did Weber and coworkers arrive at this startling finding? Yeast RNase P consists of nine protein subunits and an RNA component that comes from the RPR1 gene.  The first thing Weber and coworkers did was to show that the lethal phenotype of a rpr1 knockout could be rescued by the single-subunit RNase P from either the plant Arabidopsis thaliana or the trypanosome Trypanosoma brucei.  The RNase P in these beasts consists of only a single polypeptide.

The authors next integrated the RNase P gene of A. thaliana into the genome of a yeast cell lacking both RPR1 and one of the protein subunits of RNase P, Rpr2p, and put it through a set of rigorous tests.  To their surprise, they found that this strain does a perfectly fine job of processing tRNA precursors.  There was no buildup of intermediates and, if anything, the A. thaliana RNase P proved to be a bit more efficient at trimming these tRNA precursors.

Of course just because the simpler RNase P can substitute for the RNA subunit of the more complex RNase P, that does not mean the two do the exact same thing.  It could be that the more complex form of RNase P has a broader set of functions, but that the only function absolutely required for life is the trimming of tRNA precursors.  But this does not appear to be the case.

Previous research showing that unprocessed forms of other RNAs accumulate at the restrictive temperature in an rpr1-ts mutant had suggested that yeast RNase P also processes a number of other RNAs besides tRNAs.  Since Weber and coworkers didn’t see these unprocessed forms accumulating in their strain, either the simple A. thaliana RNase P was able to process those other RNAs, or they’re actually not RNase P substrates. 

By analyzing the phenotypes of several different RNase P mutants, they showed that the other RNAs aren’t RNase P substrates; apparently their accumulation in the rpr1-ts mutant is an indirect effect.  All in all, these results show that the added complexity of yeast RNase P did not arise so that the enzyme could also process these other RNAs.

The authors next set out to see if there was any subtle difference between the two strains.  In other words, does replacing the RNA component of yeast RNase P with the catalytic protein subunit from A. thaliana have any effect on the yeast whatsoever? 

Weber and coworkers tested this by comparing the growth of the two strains under a wide range of conditions.  They saw no significant effects in any of the over 30 conditions tested.  If the yeast RNase P has any added features over the A. thaliana one, they are very, very subtle.

Pushing to see if they could find any differences, they even set the two up in direct competition to see which was the best suited for survival.  They did this by adding GFP to one or the other strain so that they could follow it, putting the two strains together, and growing them for many generations to see if one routinely outcompeted the other.  Neither did…it was a draw.  There appears to be no advantage to having the yeast RNase P despite its complexity!

This is weird.  It is almost like round trip evolution.  RNase P starts out as a single RNA that processes tRNA precursors.  Then as it moves around the tree of life, it picks up various bells and whistles and occasionally is even replaced by a protein.  And yet in the end, all RNase P’s are strangely equivalent.  As if all of that evolving was for naught!

Obviously there are still plenty of unanswered questions.  Why did yeast build up this complexity if there is seemingly no advantage?  And is the protein subunit superior to the RNA subunit?  If so, this last question would at least explain why a few beasts evolved away from the RNA catalytic subunit to the protein one – but still wouldn’t answer why all those proteins are glomming onto the perfectly adequate RNA that probably predates proteins.  More studies in yeast may help us “unmask” the answer to this fundamental question.

by D. Barry Starr, Ph.D., Director of Outreach Activities, Stanford Genetics

Categories: Research Spotlight

Tags: evolution, RNase P, Saccharomyces cerevisiae, tRNA processing

New Sequence, Chromosome, and Contig pages

August 25, 2014

New Sequence pages are now available in SGD for virtually every yeast gene (e.g., HMRA1 Sequence page), and include genomic sequence annotations for the Reference Strain S288C, as well as several Alternative Reference Genomes from strains such as CEN.PK, RM11-1a, Sigma1278b, and W303 (more Alternative References coming soon). Each page includes an Overview section containing descriptive information, maps depicting genomic context in Reference Strain S288C (as shown below) and Alternative Reference strains, as well as chromosomal and relative coordinates in S288C.

The sequence itself includes display options for genomic DNA, coding DNA, or translated protein.

Also available on each Sequence page are links to redesigned S288C Chromosome pages, links to new Contig pages for Alternative Reference Genomes, and a Downloads menu for easy access to DNA sequences of several other industrial strains and environmental isolates. The new Sequence, Chromosome, and Contig pages make use of many of the features you enjoy on other new or redesigned pages at SGD, including graphical display of data, sortable tables, and responsive visualizations. The Sequence pages also provide seamless access to other tools at SGD such as BLAST and Web Primer. Please explore these new pages, accessible via the Sequence tab on your favorite Locus Summary page, and send us your feedback.

Categories: Data updates, New Data, Sequence, Website changes

Special Delivery for Cytotoxic Proteins

August 21, 2014

Like the USPS delivering a letter, yeast Cue5p & human Tollip recognize the ubiquitin “stamp” on cytotoxic proteins and present them to the “addressee” Atg8p. Image from Wikimedia Commons

Say you want to send a letter to your friend on the other side of the country. First off you’ll need to put the right address and postage on the envelope. Then you’ll need the U.S. Postal Service (USPS) to take your letter and deliver it to the right person. The stamp tells the USPS to deliver the letter, and the address indicates where it should be delivered (unimpeded by snow nor rain nor heat nor gloom of night, of course!).

It turns out something similar happens in human cells with aggregated proteins. Aggregated proteins are “stamped” by attachment of the small protein ubiquitin and “addressed” to the Atg8 protein. Atg8p triggers the aggregated proteins’ incorporation into autophagosomes for eventual degradation in the lysosome.

And just as it can be devastating if your mail doesn’t get to where it needs to go, so too can it be devastating for these aggregates to accumulate instead of being properly delivered. A buildup of these aggregates is a big factor in Alzheimer’s and Huntington’s diseases.

Enter the cellular USPS. Just as is the case for a prepared letter, the human cell has a service that delivers the ubiquinated proteins to the autophagosome, in the form of the protein adaptor p62 (SQSTM1) and its relative, NBR1.

These adaptor proteins can act as a postal service because they recognize both the aggregated proteins’ stamp (ubiquitin) and their addressee (Atg8p). Specifically, they each possess an ubiquitin-conjugate binding domain (UBA) and an Atg8-interacting motif (AIM). The protein p62 in particular has been shown to associate with protein aggregates linked to neurodegenerative diseases like Huntington’s disease.

In a new paper published in Cell, Lu et al. asked whether there is a link between the ubiquitin and autophagy systems in yeast. If so, yeast might provide some clues about diseases like Huntington’s. Proteins stamped with ubiquitin are known to be addressed to the proteasome for degradation in yeast, but no link between ubiquitination and autophagy had previously been seen, even though many central components of autophagy were actually first described in yeast.

Indeed, the authors showed that cells specifically deficient in the autophagy pathway (atg8∆, atg1∆, or atg7∆), accumulated ubiquitin conjugates under autophagy-inducing conditions. This suggests that the ubiquitin and autophagy pathways are connected in yeast, as is the case for humans.

Next, the researchers looked to see if there is an adaptor in yeast analogous to p62 in humans. When they pulled down proteins that bind yeast Atg8p under starvation conditions, they found ubiquitin conjugates and, using mass spectrometry, further identified peptides from a few other proteins – one of which was Cue5p.

Could Cue5p, like p62 in humans, be the postal service that recognizes both stamped ubiquitin conjugates and the addressee Atg8p in yeast? Strikingly, Cue5p had both a CUE domain that binds ubiquitin and an Atg8p-interacting motif (AIM). The authors confirmed in vivo that Cue5p binds ubiquitin conjugates and Atg8p using these domains, particularly under starvation conditions. They also showed that it acts specifically at the stage of ubiquitin-conjugate recognition and on aggregated proteins, without affecting the process of autophagy itself.

Given that Cue5p functions similarly to p62 and p62 is known to associate with protein aggregates involved in neurodegenerative disease, Lu et al. were quick to look for Cue5p substrates. Analyzing ubiquitin-conjugated proteins that accumulated in cue5 mutant cells, they identified 24 different proteins. Although these 24 Cue5p substrates had diverse functions, the common thread was that many had a tendency to aggregate under certain conditions such as high temperature.

Could Cue5p then actually facilitate removal of cytotoxic protein aggregates in neurodegenerative diseases? Indeed, the authors showed that CUE5 helped clear cytotoxic variants of the human huntingtin protein (Htt-96Q) when it was expressed in yeast, and that Htt-96Q is ubiquitinated in yeast.

These experiments started with an observation in human cells that prompted discovery of an analogous system and adaptor protein in yeast. Now the authors turned the tables and used yeast to look for new adaptor proteins in human cells. Using bioinformatics, they identified a human CUE-domain protein, Tollip, which, although different in its domain organization from Cue5p, contains 2 AIM motifs.

To make a long story (and a lot of work!) short, they showed that Tollip binds both human Atg8p and ubiquitin conjugates and clears cytotoxic variants of huntingtin in human cells. Expressed in yeast, it similarly binds ubiquitin conjugates and Atg8p and suppresses the hypersensitivity of cue5∆ cells to the variant huntingtin protein Htt-96Q. So Tollip is a newly defined adaptor protein and functional homolog of Cue5p!

Letter carriers of one sort or another have been around for as long as human civilization has existed, from homing pigeons to FedEx. Now we know that for even longer, cells from yeast to human have been using similar ways to recognize stamped proteins and deliver them to the right address. And once again, yeast has helped us understand the inner secrets of human cells.

by Selina Dwight, Ph.D., Senior Biocurator, SGD

Categories: Research Spotlight, Yeast and Human Disease

Tags: autophagy, cytotoxic proteins, Saccharomyces cerevisiae, ubiquitin-mediated degradation, yeast model for human disease

Pinpointing Peroxisomes

August 14, 2014

The contents of the cell certainly move around, but they’re not quite as mobile as the blobs in this lava lamp. Image from Wikimedia Commons

One way to think about the cell is that organelles float around in it like those globs in a lava lamp.  This is obviously a simplification, but it’s also true that organelles aren’t locked into place.  As usual, the real picture lies somewhere in between these two extremes.

What we know about the architecture of the cell has mostly been discovered using classical cell biology and genetic techniques. But in a paper published in Molecular BioSystems, Cohen et al. uncovered some very interesting small details using a very large-scale approach.

The authors were interested in peroxisomes, where a lot of critical metabolic reactions happen (or fail to happen, in several human diseases). The researchers were able to see that peroxisomes not only interact with other organelles, but they contact the endoplasmic reticulum (ER) and mitochondria in a way that could be extremely important for cellular metabolism. And surprisingly, it was by combining a variety of different high-throughput techniques that Cohen and colleagues could uncover this fine structure.

The first step was to set up two reporter constructs to look for genes involved in two different peroxisomal processes.

One reporter was a red fluorescent protein, mCherry, modified to carry a peroxisomal targeting signal and show whether import into peroxisomes was normal. Another reporter, a peroxisomal membrane protein (Ant1p) tagged with green fluorescent protein (GFP), would show whether peroxisomal membranes were normal.

The reporters were crossed into mutant collections, creating one strain for each gene in the genome that had either a complete deletion (for nonessential genes) or a knock-down allele (for essential genes), plus both reporters. Now the researchers could systematically test for genes that, when mutated, affected one or both of these aspects of peroxisomal biogenesis.

To visualize the mutant phenotypes, they used a sophisticated technique termed “high-content screening.” This is an automated way to analyze micrographs that both pinpoints the intracellular location of a fluorescent reporter and measures its quantity. Screening the mutant collection in this way showed that 56 strains had altered distribution of the two different reporter proteins.  Some had a reduction in peroxisomal protein import (mCherry fluorescence), while some had fewer or no peroxisomes and some had peroxisomes that were smaller than normal (GFP fluorescence).

One result that caught the researchers’ eyes was that one of the strains with smaller peroxisomes had a mutation in the MDM10 gene. Mdm10p is part of the ERMES (ER-Mitochondria Encounter Structure) complex that tethers mitochondria to the ER, and this wasn’t previously known to have any connection with peroxisomes. Strains that were mutant in other ERMES subunits had the same phenotype, confirming that the complex has something to do with peroxisome structure.  Other results from the screens added weight to the idea of a three-way connection between peroxisomes, the ER, and mitochondria, and the authors went on to show that peroxisomes often sit at the ERMES complex where mitochondria contact the ER.

Next, to test whether mitochondria might have specific subdomains where peroxisomes interact, the authors used yet another large-scale screen. In the C-terminal GFP fusion library, where each yeast open reading frame is C-terminally tagged with GFP, 96 strains showed a punctate pattern of the fluorescent signal – meaning that the protein was concentrated in spots, rather than evenly distributed.  They labeled the mitochondria with a red fluorescent marker protein in these strains and, again using the high-content screening system, identified protein spots that co-localized with mitochondria. The most intense hit was for Pda1p, a subunit of the mitochondrial enzyme pyruvate dehydrogenase (PDH), and a similar result was obtained for another PDH subunit. So PDH isn’t distributed uniformly in the mitochondrion, but is instead concentrated in clusters.

Looking more closely using the various reporter constructs in their collections, the authors found that peroxisomes and the ERMES complex most often co-localized with those mitochondrial globs of PDH. It would make metabolic sense for peroxisomes to hang out near PDH on mitochondria because this could increase the local concentration of metabolites that they both use.

Intriguingly, Cohen et al. also found that mitochondria and peroxisomes co-localized in mammalian cells. Given that many diseases are linked to peroxisomal metabolism, this is an important avenue to investigate.

So while organelles don’t float around in the cell quite as fluidly as the globs in a lava lamp, the data generated from large-scale approaches boiled down to learning some very fine-grained detail about cellular architecture. We think that’s, like, groovy.

by Maria Costanzo, Ph.D., Senior Biocurator, SGD

Categories: Research Spotlight, Yeast and Human Disease

Tags: endoplasmic reticulum, mitochondria, peroxisomes, Saccharomyces cerevisiae

Shmoos Lost in Translation

August 07, 2014

Yeast cells don’t always shmoo…but when they do, they prefer eIF5A. Image courtesy of Gabriel Fox

To mate, the yeast Saccharomyces cerevisiae needs to shmoo — to generate a projection that reaches out to a nearby yeast of the opposite sex, until the yeast cell is shaped like the Al Capp cartoon character.  And to shmoo yeast needs, among other things, polyamines like spermidine.

Spermidine is important for one of the most interesting proteins in the world, the translation initiation and elongation factor eIF5A.  Not only is this protein pretty much conserved in just about every living thing, but it is also the only protein to have the unique amino acid hypusine.  And to make things even more fascinating, there are two other conserved proteins whose only job is to convert a single lysine residue of eIF5A into hypusine, using polyamines like spermidine.  Simply mind boggling.

In a new study in GENETICS, Li and coworkers provide compelling evidence that spermidine is important in yeast shmooing because of its involvement in the hypusinylation of eIF5A.   They also found that one reason eIF5A is so important in this process is that it is necessary for translating Bni1p, a formin needed to organize the actin cables of the shmoo.  Without these actin cables, the shmoo can’t form.

It looks like yeast needs eIF5A to translate Bni1p because of the long stretches of prolines found in this protein.  This suggests that like its bacterial ortholog EF-P, a key job for eIF5A is to help the cell deal with polyproline stretches in proteins.

To show this the researchers made a set of targeted mutations to check whether hypusinylation of eIF5A is necessary for shmooing.  When they knocked out LIA1, one of the enzymes that uses spermidine to convert lysine to hypusine, the resulting yeast failed to shmoo.  Since the only known target of the Lia1 protein is eIF5A, this suggests that hypusinylation of eIF5A is critical to its function in shmooing.

They also used temperature sensitive mutants of eIF5A to show that this gene (HYP2, also known as TIF51A) is involved in shmooing.  At the nonpermissive temperature, only 7.7% of yeast with the less severe mutant allele, tif51A-1, shmooed, while none of the yeast with the more severe mutation, tif51A-3, were able to shmoo.  These two results taken together establish the importance of eIF5A in shmooing.

Because eIF5A was known to be important for translating polyproline regions, the researchers looked for yeast proteins with such stretches, with the idea that their failure to be translated may be behind the need for eIF5A in shmooing.  They found 549 such proteins, and a comparison of their Gene Ontology (GO) annotations showed four overrepresented categories including “mating projection” (shmoo).  They focused on a protein from this group, Bni1p, because it was known to be involved in shmoo formation and it was one of only two proteins with ten or more prolines in a row. 

Bni1p is important for organizing the actin cables that are needed to make a shmoo.  Li and coworkers showed that the temperature sensitive mutants of eIF5A and bni1 mutants had similar phenotypes in terms of actin organization in the shmoo.

So the idea here is that yeast need eIF5A to shmoo because they need eIF5A to translate Bni1p, and Bni1p is needed to set up the actin framework of the shmoo.  In this hypothesis, it is the indirect action of eIF5A that prevents the shmooing. To test this hypothesis, the authors generated a bni1 mutant that lacked the polyproline regions. 

They compared the transcript levels of wild type BNI1 and the mutant lacking the polyproline stretches using RT-qPCR and found that the presence of eIF5A didn’t matter much.  The transcript levels of the mutant and wild type BNI1 were pretty much the same.

It was a different story for the protein levels.  Using Western blots Li and coworkers saw very little wild type Bni1p, but lots of the mutant protein.  The yeast cells struggled to translate wild type Bni1p but had no trouble with the mutant.  The easiest explanation is that eIF5A is needed to help the yeast translate polyproline regions of proteins, including Bni1p. 

Finally, to confirm the eIF5A and Bni1p connection, they showed that additional Bni1p could partially overcome the shmoo defect of the temperature sensitive mutants of eIF5A.  Since this suppression was only partial, and since the mutant phenotype of the eIF5A mutant is more severe than that of the bni1 mutant, there are probably other proteins involved in shmooing that require eIF5A for translation. Some likely candidates are those proteins containing polyproline stretches that are annotated to the GO term “mating projection”.

Although a connection between oddly-shaped yeast cells and human fertility and/or disease may not seem obvious, there might indeed be one. It turns out that eIF5A is so highly conserved  that human eIF5A works just fine when expressed in yeast, and mammalian formins, like Bni1p, are also proline-rich. Formins are necessary for polarized growth, which is a feature of both reproductive cell and cancer cell growth, and spermidine is required for fertilization.

Hard to believe that yeast channeling a cartoon character can teach us so much about the most fascinating of proteins, eIF5A.  And maybe even shed light on our own fertility. 

by D. Barry Starr, Ph.D., Director of Outreach Activities, Stanford Genetics

Categories: Research Spotlight

Tags: eIF5A, hypusine, Saccharomyces cerevisiae, translation

Time Flies Like an Arrow, Fruit Flies Like a Grande Yeast

July 31, 2014

Yeast need working mitochondria to make these bananas extra attractive to fruit flies. Image from Wikimedia Commons

Here at SGD we tend to have a totally positive opinion of yeast.  As we have said before, they give us bread, booze, a great model organism, and even our livelihoods.  But in truth, Saccharomyces cerevisiae has a few minor faults.

For example, you can thank yeast for all those irritating fruit flies buzzing around your brown bananas.  Fruit flies aren’t attracted to the rotting fruit itself.  They are instead attracted to chemicals the yeast cells are pumping out as they nosh on that old banana.

In a new study, Schiabor and coworkers set out to identify the genetic differences that make some yeast strains more attractive to fruit flies as compared to other strains.  They found that the flies can actually tell the difference between “petite” yeast, with defective mitochondria, and “grande” yeast whose mitochondria are normal.  The mitochondria play a huge role in determining which volatile chemicals a yeast will release, and so determine which yeast are the most attractive to a fruit fly.  But the mitochondria are probably not involved in the way that you might be thinking…

In the first experiment, the authors tested a bunch of different yeast strains to find the ones that fruit flies prefer. As expected, they found a wide range of yeast attractiveness.  They decided to focus on BY4741 as the more appealing strain and BY4742 as the less appealing one.

Schiabor and coworkers chose these two strains both because they are isogenic and because they are the strains from which the systematic yeast deletion collection was made.  These two attributes mean that it should be relatively easy to track down the genetic difference in each strain’s attractiveness to fruit flies.

The first obvious candidate was the different auxotrophies in each strain. Although the strains are isogenic overall, they have a few small differences: BY4741 is a met17 mutant and is mating type a, while BY4742 is a leu2 mutant and is mating type α. Since amino acids are very important in creating various volatile chemicals, the mutations in the amino acid biosynthetic genes seemed a likely cause of the difference in the way the two strains smelled to fruit flies. However, the authors found that none of the auxotrophic mutations mattered.  When they mated the two strains and did tetrad analysis to obtain every possible genetic combination, they found that each of the eight new strains was preferred over BY4742.

Given the non-autosomal inheritance of attractiveness, an obvious candidate was the mitochondria. This hunch was confirmed in a couple of ways.  First, Schiabor and coworkers showed that every strain except BY4742 grew well on glycerol, and second, they found that an isolate of BY4742 with functional mitochondria, BY4742g, was as attractive to fruit flies as BY4741.  Apparently their stock of BY4742 had lost mitochondrial function (which can happen fairly easily for some strains), and clearly the mitochondria matter here!

Through a series of experiments we don’t have the space to describe here, the authors found that the lack of attractiveness was not due to an inability to respire.  Instead, by growing each strain on different nitrogen sources, they were able to provide evidence that mitochondrial functions like proline catabolism and/or branched amino acid anabolism were more likely to be involved.  It can sometimes be hard to remember that the mitochondrion is more than the powerhouse of the cell we all learned about in high school: a lot of very important metabolic reactions other than respiration happen within the mitochondrial compartment.

The authors think that yeast with good working mitochondria are the most useful to fruit flies, which is why fruit flies have evolved to be attracted to those yeast.  This all makes sense, as yeast and fruit flies have a mutually beneficial relationship.  Yeast serve as food for fruit fly larvae, and the ethanol they produce also protects those same fruit fly larvae from predators.  Fruit flies can open up parts of the fruit the yeast can’t get to and help move the yeast to different places.   

The bottom line is that you can blame yeast mitochondria for that swarm of fruit flies hovering over your fruit bowl.  One day maybe we can come up with a way that our fruit will only allow petite yeast to grow.  Then we’ll have a bit of time to enjoy fruit that isn’t attractive to fruit flies.  Until, of course, the flies evolve to prefer petite yeast…

by D. Barry Starr, Ph.D., Director of Outreach Activities, Stanford Genetics

Categories: Research Spotlight

Tags: Drosophila, mitochondria, Saccharomyces cerevisiae

SGD Summer 2014 Newsletter

July 28, 2014

SGD periodically sends out its newsletter to colleagues designated as contacts in SGD. This Summer 2014 newsletter is also available on the community wiki. If you would like to receive the SGD newsletter in the future please use the Colleague Submission/Update form to let us know.

Categories: Newsletter

Look for SGD at the Yeast Genetics Meeting in Seattle!

July 23, 2014

SGD staff will be attending the GSA Yeast Genetics Meeting in Seattle, July 29 – August 2, 2014 en force! We will be hosting a Workshop, Posters, and an Exhibit Table. The Workshop, “Computational Tools at SGD,” is on Thursday, July 31 at 1:30 PM in Kane Hall, Room 220. We will be discussing our powerful search tool, YeastMine, what’s new in the realm of Strains and Sequences, and new displays in SGD. Bring your questions and comments – we love feedback!

Follow @yeastgenome and #YEAST14 on Twitter for the latest research being presented at YGM.

Find these SGD staff members, as well as those presenting posters, at the Workshop and the Exhibit table:</p?


Maria Costanzo
Workshop Speaker
Rob Nash
Rob Nash
Workshop Speaker
Ben Hitz
Ben Hitz

Workshop: “Computational Tools at SGD”

Thursday, July 31, 1:30 – 3:00 PM
Kane Hall, Room 220
Featured topics: YeastMine (our powerful search tool), Sequences and Strains update, New data displays at SGD

Posters

In addition to the Workshop, SGD curators will present 4 posters – please stop by and chat with us.

Poster Date & Time Poster Title Presenter
318C Friday, August 1
7:30 – 8:30 PM
HUB Grand Ballroom
Defining the transcriptome of Saccharomyces cerevisiae Edith Wong
Edith Wong
387C Friday, August 1
8:30 – 9:30 PM
HUB Grand Ballroom
Yeast – it simply has a lot to say about human disease Selina Dwight
Selina Dwight
411C Friday, August 1
8:30 – 9:30 PM
HUB Grand Ballroom
Transcriptional regulation and protein complexes in budding yeast Stacia Engel
Stacia Engel
459C Friday, August 1
8:30 – 9:30 PM
HUB Grand Ballroom
Staying current and modern: Overhauling an actively-used model organism database website Kelley Paskov
Kelley Paskov

Exhibit Table

SGD will also have an exhibit table at the YGM. Come by to take a spin on our site, receive a prize for taking a survey, learn about various features of the database, and provide us with feedback as to what we can do to improve SGD. Look for us wearing our SuperBud fleece jackets, and feel free to flag any of us down!

Categories: Conferences, News and Views

Next

© Stanford University, Stanford, CA 94305.